Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.515 USD | +0.43% | -9.40% | -30.18% |
05-15 | PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.18% | 128M | |
+7.71% | 113B | |
+10.40% | 106B | |
+0.41% | 22.27B | |
-11.91% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.36% | 17.24B | |
+7.02% | 14.29B | |
+36.25% | 12.52B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- PDS Biotechnology : Oppenheimer Adjusts PDS Biotechnology PT to $12 From $7, Maintains Outperform Rating